Value in Health：仿真模型有助追踪现察乳腺癌患者

2014-11-25 佚名生物谷

近日，刊登在国际杂志Value in Health上的一篇研究论文中，来自阿德莱德大学的研究人员通过研究评估了国际乳腺癌指南，其或可有效改善乳腺癌患者的监督及健康防护。每年推荐的乳腺癌国际指南都会追踪每一位早期乳腺癌患者疗法后的乳房x光检查结果，研究者在文章中阐明，绝经后的女性进行适度的早期乳腺癌诊断及较低频率的监督或许更为划算，尤其是对于70岁以上的女性来讲。 Jon Karnon教授表示，由

近日，刊登在国际杂志Value in Health上的一篇研究论文中，来自阿德莱德大学的研究人员通过研究评估了国际乳腺癌指南，其或可有效改善乳腺癌患者的监督及健康防护。每年推荐的乳腺癌国际指南都会追踪每一位早期乳腺癌患者疗法后的乳房x光检查结果，研究者在文章中阐明，绝经后的女性进行适度的早期乳腺癌诊断及较低频率的监督或许更为划算，尤其是对于70岁以上的女性来讲。

Jon Karnon教授表示，由于进行了早期的诊断及疗法的改善，因此乳腺癌幸存患者的数量一直在上升，所有这些女性患者都需要进行乳房x光检查来检测疾病的复发。但当诊断和疗法可以明显改善许多癌症患者的预后时，癌症的监督方法将不会再进行改变了。

本文的研究结果显示，年轻的绝经后女性乳腺癌复发的风险适中，需要连续5年每年进行乳腺癌复发的筛查并且每两年进行一次随访，这种方式对于这类女性非常划算；而对于老年女性来讲，每隔两年进行乳房x光检测或许更加划算一些。

基于当前的研究数据及仿真模型研究，研究人员就可以根据患者的年龄及原发性乳腺癌的特性，对进行替代乳房x光检查流程的女性进行长期的效益及健康状况的预测；Taryn Bessen教授表示，满足每年进行乳房x光检查的国际指南或许对于早期乳腺癌女性并不必要；当前的研究结果强调了乳腺癌患者遵循治疗指南后乳腺癌复发的可能性，当然新型仿真模型技术的使用或可帮助指导临床实践来有效改善乳腺癌患者的预后。

原始出处

Bessen T1, Karnon J2.A patient-level calibration framework for evaluating surveillance strategies: a case study of mammographic follow-up after early breast cancer.Value Health. 2014 Sep

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1796676, encodeId=cc1c1e9667612, content=<a href='/topic/show?id=68ea18269ff' target=_blank style='color:#2F92EE;'>#value#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18269, encryptionId=68ea18269ff, topicName=value)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Mar 16 09:27:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860982, encodeId=8b731860982f2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Sun Nov 30 18:27:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570935, encodeId=5c9015e0935d7, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621509, encodeId=0eb216215098c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=)]
2015-03-16 12498f17m66暂无昵称

#value#

25 0
[GetPortalCommentsPageByObjectIdResponse(id=1796676, encodeId=cc1c1e9667612, content=<a href='/topic/show?id=68ea18269ff' target=_blank style='color:#2F92EE;'>#value#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18269, encryptionId=68ea18269ff, topicName=value)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Mar 16 09:27:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860982, encodeId=8b731860982f2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Sun Nov 30 18:27:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570935, encodeId=5c9015e0935d7, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621509, encodeId=0eb216215098c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=)]
2014-11-30 shizhenshan

#ALT#

35 0
[GetPortalCommentsPageByObjectIdResponse(id=1796676, encodeId=cc1c1e9667612, content=<a href='/topic/show?id=68ea18269ff' target=_blank style='color:#2F92EE;'>#value#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18269, encryptionId=68ea18269ff, topicName=value)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Mar 16 09:27:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860982, encodeId=8b731860982f2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Sun Nov 30 18:27:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570935, encodeId=5c9015e0935d7, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621509, encodeId=0eb216215098c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=)]
2014-11-27 hb2008ye

#乳腺癌患者#

22 0
[GetPortalCommentsPageByObjectIdResponse(id=1796676, encodeId=cc1c1e9667612, content=<a href='/topic/show?id=68ea18269ff' target=_blank style='color:#2F92EE;'>#value#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18269, encryptionId=68ea18269ff, topicName=value)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Mar 16 09:27:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860982, encodeId=8b731860982f2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Sun Nov 30 18:27:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570935, encodeId=5c9015e0935d7, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621509, encodeId=0eb216215098c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Nov 27 00:27:00 CST 2014, time=2014-11-27, status=1, ipAttribution=)]
2014-11-27 yyanpro@28cn.c

#Health#

29 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科

Value in Health：仿真模型有助追踪现察乳腺癌患者

相关资讯

科室

工具

服务